As of 2025-07-03, the Intrinsic Value of Bio-Techne Corp (TECH) is 42.49 USD. This TECH valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 52.08 USD, the upside of Bio-Techne Corp is -18.40%.
The range of the Intrinsic Value is 28.42 - 86.71 USD
Based on its market price of 52.08 USD and our intrinsic valuation, Bio-Techne Corp (TECH) is overvalued by 18.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 28.42 - 86.71 | 42.49 | -18.4% |
| DCF (Growth 10y) | 31.93 - 89.79 | 45.98 | -11.7% |
| DCF (EBITDA 5y) | 31.81 - 38.50 | 34.23 | -34.3% |
| DCF (EBITDA 10y) | 35.25 - 44.55 | 38.88 | -25.3% |
| Fair Value | 21.00 - 21.00 | 21.00 | -59.68% |
| P/E | 24.78 - 35.14 | 30.00 | -42.4% |
| EV/EBITDA | 30.13 - 36.36 | 33.26 | -36.1% |
| EPV | 22.92 - 29.30 | 26.11 | -49.9% |
| DDM - Stable | 10.25 - 40.00 | 25.13 | -51.7% |
| DDM - Multi | 22.80 - 66.32 | 33.60 | -35.5% |
| Market Cap (mil) | 8,164.58 |
| Beta | 0.73 |
| Outstanding shares (mil) | 156.77 |
| Enterprise Value (mil) | 8,353.91 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.81% |
| Cost of Debt | 4.25% |
| WACC | 7.66% |